| UROLOGY MAIN SITE | GEN. ADULT UROLOGY | UROLOGIC ONCOLOGY | MALE UROLOGY | TRANSPLANT PROGRAM | |
| PELVIC MEDICINE, INCONTINENCE & RECONST. SURGERY | PEDIATRIC UROLOGY | MIN. INVASIVE SURGERY | |||
|
Nazy Zomorodian, RNC, MSN, CUNP, CCRC
a Curriculum Vitae
|
|
||||||||||||||||||||||||||
| Educational Background | |
|
|
|
| Undergraduate: | Bachelor of Sciences in Nursing Program MCP/Hahnemannn University Philadelphia, PA |
| Medical School: | Master of sciences in Nursing Primary Care Nurse Practitioner Program MCP/Hahnemann University Philadelphia, PA |
| Board Certifications & Fellowships: |
Certified Clinical Research Coordinator (CCRC) Association of Clinical Research Professional (ACRP) Board Certification in Urology for Nurse Practitioner |
| Professional Memberships | |
|
|
|
| Association of American Urological Nursing American College of Nurse Practitioners Honor Society of Nursing, Sigma Theta Tau International |
| Academic & Medical Staff Appointments | |
|
|
|
| Assistant Professor, Department of Urology, David Geffen School of Medicine at UCLA |
| Research & Clinical Interests | |
|
|
|
| Nazy Zomorodian, RNC, MSN, CUNP, CCRC earned her Master's Degree in Nurseing, is a board certified Nurse Practitioner, and is also certified by the Association of Clinical Research as a Clinical Research coordinator. Ms. Zomorodian is currently working on her PhD in Nursing Research at the UCLA School of Nursing. |
Additional Information |
|
|
|
|
PUBLICATIONS
§ A Monoclonal Antibody (Mab) in patients with Advanced Cancer: Phase I Clinical Results, Hyung L. Kim, Allan J. Pantuck, Arie S. Belldegrun, Nazy Zomorodian. ASCO 2002, 21:35A.
§ Bone Metastasis Disease and Renal Cell Carcinoma, Nazy Zomorodian, Nancy Moldawer. Biotherapy: Nursing Journal, Feb 2004
§ High-dose Interleukin-2 Therapy for Metastasis Kidney Cancer, Nancy Moldawer, Nazy Zomorodian. Biotherapy: Nursing Journal, Feb 2004
POSTER PRESENTATION
§ A Phase II Trial of Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) and Recombinant Human Interleukin-4 (IL-4) Used as Combination Therapy for Subjects with Hormone Refractory Prostate Cancer.
National Cancer Institute, Rockville, MD
POSTER PRESENTATION
§ A Phase II Trial of Recombinant Human Granulocyte Macrophage-Colony Stimulating Factor (GM-CSF) and Recombinant Human Interleukin-4 (IL-4) Used as Combination Therapy for Subjects with Hormone Refractory Prostate Cancer.
National Cancer Institute, Rockville, MD
